HomeRAINBOW › Filing
🔔 Get instant alerts when RAINBOW files quarterly results on BSE Start free trial →

Press Release

Filed: 30 Jul 2026, 17:36 IST Exchange: NSE Category: Financial Results — Press Release
Press Release - Q1FY27 - Revenue 4.7bn +33.2% y-y; EBITDA 1.35bn +29.9% y-y (margin 28.6%, -71 bps y-y); PAT 625m +16.2% y-y - Strong growth across mature and new hospitals with inpatient admissions +28%, outpatient +25%, deliveries +23% in Q1 FY27 - Signed agreement for 100-bed hospital in Mumbai, operations to start Q1 FY28 - Acquired 70-bed hospital in Nellore and 50-bed new hospital in Guntur, expanding Andhra Pradesh presence - Ongoing projects in Indore, Coimbatore, Gurugram, Pune, and Bengaluru progressing on schedule - Capital expenditure of Rs 563m in Q1 FY27; strong cash position of Rs 6.13bn supports expansion - Focus on digital transformation to enhance patient experience and operational efficiency
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 RAINBOW — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add RAINBOW to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Rainbow Childrens Medicare Limited

Important. The summary above is generated automatically from Rainbow Childrens Medicare Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.